Foto del docente

Milo Gatti

Ricercatore a tempo determinato tipo a) (junior)

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIOS-11/A Farmacologia

Pubblicazioni

Conti, Matteo; Giorgi, Beatrice; Barone, Rossella; Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico, A Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Measuring Fosfomycin Concentrations in Human Prostatic Tissue, «PHARMACEUTICS», 2024, 10.3390/pharmaceutics16050681, Article number: 681, pp. 1 - 12 [articolo]Open Access

Cojutti, Pier Giorgio; Pai, Manjunath P; Gatti, Milo; Rinaldi, Matteo; Ambretti, Simone; Viale, Pierluigi; Pea, Federico, An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 10.1093/jac/dkae290, pp. 1 - 12 [articolo]

Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Ambretti, Simone; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 10.1093/jac/dkae261, pp. 1 - 4 [articolo]

Gatti, Milo; Cosentino, Federica; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Clinical efficacy of cefiderocol-based regimens in patients affected by carbapenem-resistant Acinetobacter baumannii infections: a systematic review with meta-analysis, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 63, Article number: 107047, pp. 1 - 5 [articolo]

Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP, «ANTIBIOTICS», 2024, 13, Article number: 296, pp. 1 - 16 [articolo]Open Access

Conti, Matteo; Giorgi, Beatrice; Gatti, Milo; Viale, Pierluigi; Pea, Federico, Development and Validation of a Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Ceftolozane and Tazobactam in Human Plasma Microsamples, «THERAPEUTIC DRUG MONITORING», 2024, 10.1097/FTD.0000000000001236, Article number: 10.1097/FTD.0000000000001236, pp. 1 - 9 [articolo]

Palombo, Marta; Gatti, Milo; Secci, Benedetta; Cojutti, Pier Giorgio; Pea, Federico; Gibellini, Davide; Gaibani, Paolo, Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia, «EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES», 2024, 10.1007/s10096-024-04879-8, pp. 1 - 8 [articolo]

Berrino, Pasquale Maria; Gatti, Milo; Rotaru, Valeria; Bianchi, Lorenzo; Tumietto, Fabio; Sora, Elena; Schiavina, Riccardo; Brunocilla, Eugenio; Viale, Pierluigi; Pea, Federico, Efficacy of a Novel Prophylactic Scheme of Fosfomycin Trometamol in Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia: Findings from a Prospective Monocentric Single-Arm Study, «ANTIBIOTICS», 2024, 13, Article number: 424, pp. 1 - 10 [articolo]Open Access

Rinaldi, Matteo; Gatti, Milo; Tonetti, Tommaso; Nocera, Domenico; Ambretti, Simone; Berlingeri, Andrea; Nigrisoli, Giacomo; Pierucci, Elisabetta; Siniscalchi, Antonio; Pea, Federico; Viale, Pierluigi; Giannella, Maddalena, Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study, «ANNALS OF INTENSIVE CARE», 2024, 14, Article number: 36, pp. 1 - 10 [articolo]

Rinaldi, Matteo; Gatti, Milo; Tonetti, Tommaso; Nocera, Domenico; Ambretti, Simone; Berlingeri, Andrea; Nigrisoli, Giacomo; Pierucci, Elisabetta; Siniscalchi, Antonio; Pea, Federico; Viale, Pierluigi; Giannella, Maddalena, Impact of a multidisciplinary management team on clinical outcome in ICU patients affected by Gram-negative bloodstream infections: a pre-post quasi-experimental study, «ANNALS OF INTENSIVE CARE», 2024, 14, Article number: 36, pp. 1 - 10 [articolo]Open Access

Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico, Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis, «CRITICAL CARE», 2024, 28(1):123, Article number: 123, pp. 1 - 18 [articolo]Open Access

Gatti, Milo; Campoli, Caterina; Muratore, Edoardo; Belotti, Tamara; Masetti, Riccardo; Lanari, Marcello; Viale, Pierluigi; Pea, Federico, Impact of Inflammatory Burden on Voriconazole Exposure in Oncohematological Pediatric Patients Receiving Antifungal Prophylaxis after Allogeneic HCT, «MICROORGANISMS», 2024, 10.3390/microorganisms12071388, Article number: 1388, pp. 1 - 12 [articolo]

Cojutti, Pier Giorgio; Gatti, Milo; Punt, Nieko; Douša, Jiři; Zamparini, Eleonora; Tedeschi, Sara; Viale, Pierluigi; Pea, Federico, Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 63, Article number: 107038, pp. 1 - 5 [articolo]

Gatti, Milo; Cosentino, Federica; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, In reply to the Letter to the Editor regarding "Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis", «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 10.1016/j.ijantimicag.2024.107168, pp. 1 - 2 [replica/breve intervento]

Gatti, Milo; Pea, Federico, Is a high baseline inflammatory burden the major driver in causing daptomycin-induced eosinophilic pneumonia and muscular toxicity?, «CLINICAL INFECTIOUS DISEASES», 2024, 10.1093/cid/ciae017, pp. 1 - 2 [replica/breve intervento]